Dolby Laboratories (NYSE:DLB) Stock: Insider John Couling Sells 7,667 Shares

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $58.78, for a total transaction of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This trade represents a 4.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Dolby Laboratories Stock Up 0.8%

Shares of DLB traded up $0.46 during mid-day trading on Monday, reaching $59.35. 758,552 shares of the stock traded hands, compared to its average volume of 928,682. The firm has a market cap of $5.56 billion, a price-to-earnings ratio of 25.26 and a beta of 0.78. The stock has a fifty day simple moving average of $60.52 and a 200 day simple moving average of $57.61. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $72.96.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. During the same period in the prior year, the firm earned $0.78 earnings per share. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, equities research analysts expect that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.

Dolby Laboratories announced that its Board of Directors has initiated a share buyback program on Thursday, July 30th that allows the company to buyback $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 7% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.4%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors have recently modified their holdings of the business. Paragon Capital Management Inc. acquired a new stake in Dolby Laboratories in the first quarter worth $1,306,000. Hsbc Holdings PLC increased its holdings in shares of Dolby Laboratories by 396.1% in the 1st quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock worth $1,875,000 after acquiring an additional 24,958 shares during the period. Pacer Advisors Inc. increased its holdings in shares of Dolby Laboratories by 8.0% in the 1st quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock worth $31,008,000 after acquiring an additional 38,389 shares during the period. Norges Bank bought a new stake in Dolby Laboratories in the 4th quarter valued at about $54,966,000. Finally, Entropy Technologies LP acquired a new position in Dolby Laboratories during the 1st quarter valued at about $1,674,000. Institutional investors own 58.56% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on DLB shares. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, August 28th. Weiss Ratings raised Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and a consensus price target of $87.50.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc develops audio and imaging technologies for entertainment and communications. The company’s products and intellectual property are used in cinemas, televisions, mobile devices, personal computers, streaming platforms, gaming systems and automobiles to improve sound quality, picture quality and overall viewing experiences.

Dolby’s technology portfolio includes Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and Dolby Digital and Dolby AC-4 audio formats.